-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Virpax Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- Virpax Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.01M, a 66.5% increase year-over-year.
- Virpax Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$13.2M, a 2.76% increase year-over-year.
- Virpax Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$15.2M, a 29.8% increase from 2022.
- Virpax Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$21.7M, a 79.6% decline from 2021.
- Virpax Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.1M, a 178% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)